Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

The bispecific T-cell engager talquetamab (Talvey) has some distinct adverse events (AEs) compared with drugs of the same class that target B-cell maturation antigen (BCMA) in mul ...

A growing field of research suggests that some medical treatments, such as cancer therapy or vaccines, might be more ...

A metabolic enzyme studied for over seven decades has a hidden second function - it can unwind RNA and promote cell cycle progression, an additional function beyond its role in energy production, ...

Entering a cell and watching its entire inner machinery at work, how DNA is copied, how proteins are assembled, or how it splits in two, has been, for decades, an impossible dream. Now, scientists at ...

Hypertrophic scarring affects a large proportion of patients following burns, trauma, or surgery and arises from prolonged fibroblast hyperactivity and excessive extracellular matrix accumulation.

In a world that rarely switches off, sleep has quietly become one of the most overlooked pillars of wellbeing. Late nights, ...

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...

In Michigan Tech's biology teaching lab, undergraduate students research potential cancer cures with help from the humble worm.

When it succeeds 5G in 2030, the next-gen mobile network will focus on upload speeds, AI, and radar-like “sensing” of ...

Single-cell RNA sequencing of endometrial samples across the menstrual cycle identified key cell types and gene signatures ...